Matches 251 - 296 out of 296 < 1 2 3 4 5 6


Match Document Document Title
5648225 Method of using a multi-purpose beagent for subclassification of nucleated blood cells  
A multipurpose reagent system for rapid analysis of a whole blood sample allowing the determination of at least five classes of peripheral white blood cells, nucleated red blood cells, and...
5641677 Method of enhancing the immunotherapeutic activity of immune cells by depletion of CD8+ T cells  
The present invention provides a method for enhancing the immunotherapeutic activity, e.g., cytotoxicity, of immune cells by depleting immune cells of a cell subset that down-regulates the immune...
5637323 Method of mobilizing pluripotential hematopoietic stem cells with IL-7  
This invention provides a method of isolating an increased number of hematopoietic stem cells from a subject comprising a) administering interleukin-7 to the subject in an amount that mobilizes...
5631006 Immunotherapy protocol of culturing leukocytes in the presence of interleukin-2 in a hollow fiber cartridge  
An immunotherapy protocol in which leukocytes are cultured in the presence of interleukin-2 in a hollow fiber cartridge perfusion system for at least four days to achieve a harvest yield of at...
5602305 Immunodeficient animal model for studying T cell-mediated immune  
The present invention describes a novel immunodeficient rodent model comprising an organ graft, such as a human skin graft, said graft containing microvessels lined by endothelial cells, human T...
5597563 Method induction of antigen-specific immune tolerance  
A method for inducing antigen-specific immune tolerance by depletion of resident thymic antigen presenting cells (APCs) and re-population of thymus with new APCs containing the antigen for...
5593698 Suppression of proliferative response and induction of tolerance with polymorphic class II MHC allopeptides  
Described are methods for: (a) suppressing the ability of T-cells from a mammal to proliferate in response to stimulation by nonself mammalian tissue; and (b) suppressing immune response which...
5591430 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof  
Tumor rejection antigens derived from tumor rejection precursor MAGE-3 have been identified. These "TRAS" bind to the MHC-class I molecule HLA-A2, and the resulting complexes stimulate the...
5569585 In vitro assay measuring degree of activation of immune cells  
This invention is directed to a method for assaying the degree of activation of immune cells by stimulating non-resting immune cells to activity with an intracellular-acting stimulant and then...
5541103 CD34+ peripheral blood progenitor cells obtained by ex vivo expansion  
Patients suffering from certain types of cancer are treated by high-dose chemotherapy. In order to allow a recovery a process for the ex vivo expansion of peripheral blood progenitor cells is...
5529765 Rabbit model for diagnosing and testing vaccines or therapeutic agents against aids  
A rabbit model for testing anti-AIDS therapeutic agents, vaccines, and HIV-1 infection is described.
5472867 Ex vivo expansion of peripheral blood progenitor cells  
Patients suffering from certain types of cancer are treated by high-dose chemotherapy. In order to allow a recovery a process for the ex vivo expansion of peripheral blood progenitor cells is...
5462733 Immune system modulation using psoralens activated with visible light  
Methods and pharmaceutical compositions for modifying the immune response of a mammal are provided. The pharmaceutical compositions include a pharmaceutically acceptable carrier and a plurality of...
5415874 Natural killer cell lines and clones with antigen specificity  
Lymphocytes of NK phenotype were cultured with stimulator cell lines in the presence of growth factor containing medium. The resulting lines and clones derived from these lines expressed CD16...
5387583 Compositions containing corticosteroids or analogues thereof and corticosteroid buffering effective amounts of 5-androstene 3B, 17B or 5-androstene 3B, 7B, 17B triol or analogues thereof  
3β,17β-androstenediol ("βAED") and 3β,7β,17β-androstenetriol ("βAET") may be used to counteract the antiproliferative and immunosuppressive effects of hydrocortisone and other corticosteroids...
5358711 Stimulation of stem cell growth by the bryostatins  
In vivo and in vitro methods are taught for stimulating the differentiation of stem cells using certain bryostatins. Stem cells can be induced to form granulocytes, macrophages and erythrocytes....
5316763 Short-term anti-CD3 stimulation of lymphocytes to increase their in vivo acitivity  
The present invention is directed to a method of increasing the in vivo immune response of lymphocytes by stimulating the lymphocytes in vitro in the presence of an anti-CD3 monoclonal antibody...
5296353 Evaluation and treatment of patients with progessive immunosuppression  
A method of determining the level of immunosuppression in a mammal involves determining the level of expression of at least one selected TCR subunit protein, or protein in the T lymphocyte signal...
5284654 Method for the treatment of Parkinson's disease  
The present invention is directed to a method for the treatment of Parkinson's disease which affect the dopaminergic system by implanting into the brain of a host in need thereof an...
5242687 Method of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cells  
Specific and nonspecific immunomodulation, enhancement of cellular engraftment, and modulation of nonimmune cells are achieved by using various membrane-binding and soluble CD8 compositions.
5232844 Photodynamic inactivation of viruses in cell-containing compositions  
The present invention concerns the product produced by inactivating extracellular lipid enveloped pathogenic virus or intracellular pathogenic virus in a composition containing >1×109 cells/ml and...
5229115 Adoptive immunotherapy with interleukin-7  
There is disclosed an immunotherapy method for treating an individual with cancer or a viral infection comprising obtaining lymphoid cells previously exposed to a specific antigen, culturing the...
5226914 Method for treating connective tissue disorders  
The present invention is directed to various processes and devices for utilizing isolated and culturally expanded marrow-derived mesenchymal cells (i.e. mesenchymal stem cells) for treating...
5225182 Vectored drug delivery system using a cephaloplastin linking agent and a methed of using the system  
The subject invention relates to a novel method for vectored delivery of physiologically-active chemical agents to a target organ, tissue or cell of interest and uses thereof. In particular,...
5192537 Method of treating renal cell carcinoma using activated mononuclear cells, renal tumor antigen and cimetidine  
Immunoreactive cells sensitized for an antigenic marker associated with a malignant tumor are prepared in vitro by collecting the tumor patient's own mononuclear cells, depleting suppressor...
5154921 Promotion of maturation of hematopoietic progenitor cells  
A method for promoting maturation of a hematopoietic precursor cell of an animal, which method includes the step of contacting the cell with a maturation-promoting amount of GRO, a polypeptide...
5126132 Tumor infiltrating lymphocytes as a treatment modality for human cancer  
A new immunotherapeutic method of treating cancer with a combination of tumor infiltrating lymphocytes and IL-2 has been described.
5087636 Method to destroy malignant cells in mononuclear cell populations  
A method to prepare bone marrow or other hemopoietic cells free of malignant cells for autologous transplants is described. The mononuclear cells from the marrow are treated with a green porphyrin...
5081029 Methods of adoptive immunotherapy for treatment of aids  
Immunotherapeutic methods for the treatment of patients infected with the AIDS virus are described. T lymphocytes which are histocompatible with the patient and specific for the AIDS virus are...
5078996 Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor  
Macrophages and precursor monocytes are activated to exhibit tumoricidal activity by stimulation solely with granulocyte-macrophage colony stimulating factor. A patient suffering from tumors can...
5057423 Method for the preparation of pure LAK-active lymphocytes  
A method for the preparation of LAK-active lymphocytes; a method of immunotherapy utilizing these LAK-active lymphocytes, relatively homogeneous compositions of large granular lymphocytes, and...
5041289 Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells  
A method is disclosed for removing residual tumor cells from a patient with a neoplastic disorder by treating in vitro cell preparation with lymphokine activated cytotoxic cells.
5026365 Method and apparatus for therapeutically treating immunological disorders and disease states  
A unique method and apparatus for therapeutically treating immunological disorders and disease states which are characterized by the present of immunologically abnormal leukocytes in the body of...
5002879 Treatment of tumors with autologous LAK cells, interleukin-2 and an ornithine decarboxylase inhibitor  
Ornithine decarboxylase inhibitors when administered in conjunction with autologous LAK cells and interleukin-2 provide for an enhanced treatment of neoplastic disease states. This enhancement is...
4971795 Enhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotype  
DTH-Effector cells are primed with carbohydrate antigens and used to enhance the cellular immune response. Tumors have been inhibited by DTH-Effector cells primed with epiglycanin and with...
4971792 Monoclonal antibodies against glycolipid antigens  
The present invention is directed to in vitro and in vivo immunodiagnosis and immunotherapy using monoclonal antibodies reactive with difucosyl blood group antigens Y-6 and B-7-2.
4937071 Method for augmenting immune response  
A method for enhancing the ability for humoral immune response in a mammal comprising: exposing lymphocytes histocompatible with the lymphocytes of said mammal to the presence of...
4902288 Implantable immunotherapy system using stimulated cells  
This invention involves treating a patient having a tumor by introducing at the area of the tumor immunologically active cells which are antagonistic to the tumor. The cells being contained in a...
4861589 Method for therapeutically treating abnormal cells expressing a major histocompatibility complex class II antigen using cytolytic inducer T4 cells  
The present invention provides a lymphocyte-mediated immunotherapy for the treatment of human or animal subjects afflicted with abnormal or tumor cells which express a MHC Class II antigen on...
4849329 Process for preparing lymphokine activated killer cells  
There are disclosed an improved process for preparing lymphokine activated killer (LAK) cells from peripheral blood mononuclear cells, a composition consisting essentially of the LAK cells...
4844893 EX vivo effector cell activation for target cell killing  
A method and composition for killing target cells is disclosed. The method utilizes ex vivo IL-2 activation of leucocyte effector cells and arming the activated leucocyte effectors with monoclonal...
4764359 Drug compositions and their use in treating human or other mammalian patients  
Drug compositions formed as individual units, a multitude of which are employed as one or more doses, to reduce or aleviate cancer in a living being by targeting to and destroying cancer cells. In...
4749620 Encapsulated active material system  
Capsules are formed herein a liquified core while avoiding capsule core gelation by adding drops of a solution of either an anionic polymer composition or a cationic polymer composition to a...
4744933 Process for encapsulation and encapsulated active material system  
Capsules are formed herein a liquified core while avoiding capsule core gelation by adding drops of a solution of either an anionic polymer composition or a cationic polymer composition to a...
4690915 Adoptive immunotherapy as a treatment modality in humans  
The present invention discloses a new approach to the therapy of cancer in humans based on the administration of lymphokine activated killer (LAK) cells and interleukin-2 (IL-2). Twelve patients...
4639373 Stabilization of granulocytes  
Granulocytes are effectively preserved during storage for long periods of time without freezing by using as the storage medium a non-toxic buffer containing both gelatin and plasma.

Matches 251 - 296 out of 296 < 1 2 3 4 5 6